Cargando…

In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrel

OBJECTIVES: The World Health Organization recommends that all countries adopt dolutegravir-based antiretroviral therapy as the preferred regimen for all individuals living with HIV. Levonorgestrel is a commonly used hormonal contraceptive, which undergoes drug–drug interactions with some antiretrovi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roberts, Owain, Kinvig, Hannah, Owen, Andrew, Lamorde, Mohammed, Siccardi, Marco, Scarsi, Kimberly K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363158/ https://www.ncbi.nlm.nih.gov/pubmed/34328253 http://dx.doi.org/10.1111/hiv.13136

Ejemplares similares

Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
por: Scarsi, Kimberly, et al.
Publicado: (2014)

Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks
por: Scarsi, Kimberly K., et al.
Publicado: (2016)

Drug–Drug Interactions in People Living With HIV at Risk of Hepatic and Renal Impairment: Current Status and Future Perspectives
por: Cottura, Nicolas, et al.
Publicado: (2022)

Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications
por: Stader, Felix, et al.
Publicado: (2018)

Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine
por: Walimbwa, Stephen I., et al.
Publicado: (2019)

Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
por: Kinvig, Hannah, et al.
Publicado: (2022)

Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
por: Kinvig, Hannah, et al.
Publicado: (2022)

Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2020)

Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2020)

Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment
por: Bade, Aditya N., et al.
Publicado: (2021)

Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis
por: Agyemang, Nana, et al.
Publicado: (2023)

Comparison of levonorgestrel level and creamatocrit in milk following immediate versus delayed postpartum placement of the levonorgestrel IUD
por: Hopelian, Niaree G., et al.
Publicado: (2021)

Pro-Inflammatory Interactions of Dolutegravir with Human Neutrophils in an In Vitro Study
por: Theron, Annette J., et al.
Publicado: (2022)

Factors associated with uptake of contraceptives among HIV positive women on dolutegravir based anti-retroviral treatment-a cross sectional survey in urban Uganda
por: Mbabazi, Leah, et al.
Publicado: (2022)

Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda
por: Twimukye, Adelline, et al.
Publicado: (2021)

A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy
por: Ochanda, Perez Nicholas, et al.
Publicado: (2022)

Levonorgestrel-IUS system and endometrial manipulation
por: Malik, Sonia
Publicado: (2013)

Potential benefit of dolutegravir once daily: efficacy and safety
por: Fantauzzi, Alessandra, et al.
Publicado: (2013)

The promise of paediatric dolutegravir
por: Golin, Rachel, et al.
Publicado: (2021)

Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir Use
por: Crawford, Melissa, et al.
Publicado: (2020)

“It’s only fatness, it doesn’t kill”: a qualitative study on perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda
por: Alhassan, Yussif, et al.
Publicado: (2022)

In vitro assessment of some sperm function following exposure to levonorgestrel in human fallopian tubes
por: Hermanny, Alexia, et al.
Publicado: (2012)

Hysteroscopic suture of levonorgestrel-releasing intrauterine system: learning curve for in vitro simulation training
por: Huang, JinCheng, et al.
Publicado: (2023)

Pharmaceutical Metabolism in Fish: Using a 3-D Hepatic In Vitro Model to Assess Clearance
por: Baron, Matthew G., et al.
Publicado: (2017)

Non-contraceptive applications of the levonorgestrel intrauterine system
por: Rodriguez, Maria Isabel, et al.
Publicado: (2010)

Role of the levonorgestrel intrauterine system in effective contraception
por: Attia, Abdelhamid M, et al.
Publicado: (2013)

Effects of Levonorgestrel and progesterone on Oviductal physiology in mammals
por: Li, Cheng, et al.
Publicado: (2018)

Characterisation of Levonorgestrel-Resistant Endometrial Cancer Cells
por: Dore, Molly, et al.
Publicado: (2021)

Estradiol/levonorgestrel: Pulmonary thromboembolism: case report
Publicado: (2022)

Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial
por: Byakika-Kibwika, Pauline, et al.
Publicado: (2018)

Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017)

Levonorgestrel as a Potential Trigger of Acute Bilateral Central Serous Chorioretinopathy: Case Report
por: Nemet, Vedran
Publicado: (2023)

Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
por: Montanha, Maiara Camotti, et al.
Publicado: (2021)

Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
por: Montanha, Maiara Camotti, et al.
Publicado: (2022)

The Brazilian experience of implementing the active pharmacovigilance of dolutegravir
por: Batista, Cynthia Julia Braga, et al.
Publicado: (2019)

Levonorgestrel-Releasing Intrauterine System and Iron Overload Syndrome
por: Vieira da Motta, Marcia, et al.
Publicado: (2013)

The role of levonorgestrel intrauterine systems in the treatment of symptomatic fibroids
por: Wrona, Wojciech, et al.
Publicado: (2017)

Silk Fibroin Microneedle Patches for the Sustained Release of Levonorgestrel
por: Yavuz, Burcin, et al.
Publicado: (2020)

Levonorgestrel-Releasing Intrauterine System Use in Perimenopausal Women
por: Joo, Jong-Kil, et al.
Publicado: (2021)

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? A case report
por: Mulindwa, Frank, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sh8dn5r3gmt9h0bohd24v23af9